Your browser doesn't support javascript.
loading
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.
DeWitt, John C; Jordan, Justin T; Frosch, Matthew P; Samore, Wesley R; Iafrate, A John; Louis, David N; Lennerz, Jochen K.
Affiliation
  • DeWitt JC; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Jordan JT; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Frosch MP; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Samore WR; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Iafrate AJ; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Louis DN; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
  • Lennerz JK; Department of Pathology; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Neuro Oncol ; 19(12): 1640-1650, 2017 Nov 29.
Article in En | MEDLINE | ID: mdl-29016871
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Cost-Benefit Analysis / Sequence Analysis, DNA / Glioma / Isocitrate Dehydrogenase / Mutation Type of study: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2017 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Central Nervous System Neoplasms / Cost-Benefit Analysis / Sequence Analysis, DNA / Glioma / Isocitrate Dehydrogenase / Mutation Type of study: Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2017 Document type: Article Country of publication: United kingdom